(Q40390183)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

review article

1 reference

title

Gangliosides. Their role in clinical neurology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author

Eduardo Nobile-Orazio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

M Carpo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Scarlato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 April 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

576-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516857%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199447040-00002

20 October 2019

exact match

0 references

cites work

Motoneuron-disease-like disorder after ganglioside therapy

1 reference

12 December 2020

GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug

1 reference

12 December 2020

Trial of ganglioside therapy for diabetic neuropathy

1 reference

12 December 2020

Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

1 reference

12 December 2020

Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment

1 reference

12 December 2020

Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons

1 reference

12 December 2020

Ganglioside and rabbit erythrocyte membrane receptor for staphylococcal alpha-toxin

1 reference

12 December 2020

A Double Blind Placebo Controlled Trial of Mixed Gangliosides in Diabetic Peripheral and Autonomic Neuropathy

1 reference

12 December 2020

Effects of Cerebral Gangliosides in the Alcoholic Polyneuropathies

1 reference

12 December 2020

Gangliosides and their cell density-dependent changes in control and chemically transformed C3H/10T1/2 cells

1 reference

12 December 2020

[Gangliosides: a new prospective therapy of uremic neuropathy]

1 reference

12 December 2020

Uremic neuropathy. Clinical and neurophysiological data on patients on chronic hemodialysis treatment

1 reference

12 December 2020

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

1 reference

12 December 2020

Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial

1 reference

12 December 2020

Guillain-Barré syndrome and parenteral gangliosides

1 reference

12 December 2020

Gangliosides: structure, isolation, and analysis

1 reference

12 December 2020

Calcium/ganglioside-dependent protein kinase activity in rat brain membrane.

1 reference

12 December 2020

Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy

1 reference

12 December 2020

A review and predictive models of ganglioside uptake by biological membranes.

1 reference

12 December 2020

Verification of the therapeutic efficacy of the gangliosides in the treatment of peripheral polyneuritis in alcoholics

1 reference

12 December 2020

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

12 December 2020

Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex

1 reference

12 December 2020

Escherichia coli heat-labile enterotoxin. Ganglioside specificity and ADP-ribosyltransferase activity

1 reference

12 December 2020

Effect of parenteral administration of GM1 on cytokines and anti-ganglioside antibody patterns. Preliminary report in normal human individuals

1 reference

12 December 2020

A double-blind controlled trial of bovine brain gangliosides in amyotrophic lateral sclerosis.

1 reference

12 December 2020

Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b

1 reference

12 December 2020

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

1 reference

12 December 2020

Reevaluation of the role of gangliosides as receptors for tetanus toxin.

1 reference

12 December 2020

Antibody detection in Guillain-Barré syndrome

1 reference

12 December 2020

GM3 ganglioside induces hamster fibrobiast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor function

1 reference

12 December 2020

GM-1 Ganglioside for Spinal-Cord Injury

1 reference

12 December 2020

GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study

1 reference

12 December 2020

Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy

1 reference

12 December 2020

Ganglioside treatment improves recovery of alternation behavior after unilateral entorhinal cortex lesion.

1 reference

12 December 2020

Double-blind, placebo-controlled clinical trial of a mixture of gangliosides ('Cronassial') in post-herpetic neuralgia

1 reference

12 December 2020

Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

1 reference

12 December 2020

[The role of drug therapy in the treatment of nerve root lesions caused by compression. Clinical and electrophysiological study of 30 patients operated on for the removal of herniated disks]

1 reference

12 December 2020

Ganglioside structures and distribution: Are they localized at the nerve ending?

1 reference

12 December 2020

Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes

1 reference

12 December 2020

Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies

1 reference

12 December 2020

Ultrastructure of neurites and meganeurites of cortical pyramidal neurons in feline gangliosidosis as revealed by the combined Golgi-EM technique

1 reference

12 December 2020

Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting

1 reference

12 December 2020

Guillain-Barré syndrome after exogenous gangliosides in Italy

1 reference

12 December 2020

Effect of gangliosides on diabetic peripheral neuropathy

1 reference

12 December 2020

Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia.

1 reference

12 December 2020

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

12 December 2020

Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease

1 reference

12 December 2020

Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons

1 reference

12 December 2020

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

12 December 2020

Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells

1 reference

12 December 2020

Inhibition of hemolytic activity of the thermostable direct hemolysin of Vibrio parahaemolyticus by ganglioside

1 reference

12 December 2020

Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease

1 reference

12 December 2020

Anti-GM1 antibodies in patients with Guillain-Barré syndrome

1 reference

12 December 2020

Anti-GM1 IgM antibodies in motor neuron disease and neuropathy

1 reference

12 December 2020

High affinity binding of tetanus toxin to mammalian brain membranes

1 reference

12 December 2020

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

1 reference

12 December 2020

Neuronal perikarya and astroglia of rat brain: chemical composition during myelination

1 reference

12 December 2020

Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides.

1 reference

12 December 2020

Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides

1 reference

12 December 2020

Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases

1 reference

12 December 2020

Ganglioside therapy for amyotrophic lateral sclerosis: a double-blind controlled trial.

1 reference

12 December 2020

Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside

1 reference

12 December 2020

A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis

1 reference

12 December 2020

Effect of cerebral cortex gangliosides on the clinical and electromyographic evolution of "a frigore" facial paralysis. Apropos of 24 cases

1 reference

12 December 2020

Role of membrane gangliosides in the binding and action of bacterial toxins.

1 reference

12 December 2020

Biology of gangliosides: neuritogenic and neuronotrophic properties

1 reference

12 December 2020

Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease

1 reference

12 December 2020

High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species

1 reference

12 December 2020

Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins.

1 reference

12 December 2020

Effects of Brain Gangliosides on Functional Recovery in Experimental Regeneration and Reinnervation

1 reference

12 December 2020

Publication bias via suppressed criticism.

1 reference

12 December 2020

Gangliosides and neurological diseases

1 reference

12 December 2020

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

1 reference

12 December 2020

Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides

1 reference

12 December 2020

Monosialoganglioside in subarachnoid hemorrhage

1 reference

12 December 2020

Gangliosides and parkinsonism

1 reference

12 December 2020

Interaction between Clostridium botulinum neurotoxin and gangliosides

1 reference

12 December 2020

Bovine gangliosides and acute motor polyneuropathy

1 reference

12 December 2020

Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association

1 reference

12 December 2020

Anti-GM1 IgA antibodies in Guillain-Barré syndrome

1 reference

12 December 2020

Ganglioside-modulated protein phosphorylation in myelin.

1 reference

12 December 2020

Gangliosides of peripheral nerve myelin

1 reference

12 December 2020

Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases

1 reference

12 December 2020